Articles, App Notes, Case Studies, & White Papers
-
How To Achieve Precise And Flexible Dosing With Multiparticulates
6/22/2021
For orally delivered medicines, developers often must balance a drug’s “curb appeal” — its specific delivery mechanism, taste, ease of administration, and convenience — with safety and efficacy.
-
Application Of Nano-Emulsion Technology To Address Unmet Medical Needs: A Case Study Of Clopidogrel IV By 505(b)(2) Pathway
1/26/2022
Review a process where the insoluble and unstable free-base form of clopidogrel is converted to a form with acceptable drug loading and is protected from chemical degradation.
-
Fixtures And Surrogates For Combination Product Performance Testing
5/16/2025
The combination product market is consistently expanding. Transitioning from traditional vial systems to needle-based combination products presents several challenges that require careful consideration.
-
Layer By Layer: 3D Screen Printing And The Future Of Drug Development
8/15/2025
3D screen printing can produce tablets across a range of release profiles, from conventional immediate release tablets to multi-compartment drug delivery systems that mix different release profiles.
-
Meeting The Growing Demand For Pre-Filled Syringes
3/7/2023
The market for pre-filled syringes is growing rapidly. Learn more about the benefits for consumers, providers, and manufacturers, and the importance of partnering with a reliable fill finish facility.
-
De-Risking A Novel Valve Component For Use With Standard Syringe Systems
3/16/2026
A novel valve provides dual‑chamber functionality within standard syringes, keeping two liquid drugs separated until injection while reducing development risk through advanced modeling.
-
Solving The Silicone Challenge In Pre-Fillable Syringes
8/27/2024
Discover a technology platform that is revolutionizing the pre-fillable syringe market by solving the challenge of silicone sensitivity, ensuring stability for sensitive drugs.
-
4 Factors Affecting Solubility Of Drugs
2/28/2022
Improper drug solubility can lead to suboptimal drug delivery and absorption, resulting in ineffective drug efficacy and side effects, so solubility must be evaluated in the early stages of drug discovery.
-
Minimizing API Supply Chain Risks
Partnering with an API CMO can help you navigate challenges you may encounter, ensuring you are using the best quality practices and minimizing delays in getting those medicines to market.
-
Customized Release Through Dispersed Dosage Formats
6/13/2024
Typically, dosage format is based on the target product profile: how the developer envisions the product best addressing a clinical indication by maintaining population-wide efficacy.